Borislav Rusev

Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas.

Reporting tumor molecular heterogeneity in histopathological diagnosis.

Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components.

BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing.

Genomic analyses identify molecular subtypes of pancreatic cancer.

A rare case of three different tumors in the same pancreatic specimen: a case report and brief review of the literature.

Hypermutation In Pancreatic Cancer.

Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D.

Whole-genome landscape of pancreatic neuroendocrine tumours.

Fhit down-regulation is an early event in pancreatic carcinogenesis.

Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors.

Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma.

PD-1, PD-L1, and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications.

ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance.

Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine.

Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas.

Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations.

Patterns of gene mutations in bile duct cancers: is it time to overcome the anatomical classification?